Found: 34
Select item for more details and to access through your institution.
Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 178, n. 2, p. 389, doi. 10.1007/s10549-019-05398-3
- By:
- Publication type:
- Article
G-protein-coupled receptor kinase-2 is a critical regulator of TNFα signaling in colon epithelial cells.
- Published in:
- Biochemical Journal, 2017, v. 474, n. 14, p. 2301, doi. 10.1042/BCJ20170093
- By:
- Publication type:
- Article
Role of ERK signaling in bladder urothelium in response to cyclophosphamide injury.
- Published in:
- Physiological Reports, 2022, v. 10, n. 14, p. 1, doi. 10.14814/phy2.15378
- By:
- Publication type:
- Article
CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01887
- By:
- Publication type:
- Article
Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrences.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology.
- Published in:
- 2020
- By:
- Publication type:
- journal article
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics data.
- Published in:
- BMC Bioinformatics, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12859-024-05835-1
- By:
- Publication type:
- Article
Minimal Residual Disease--Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 10, p. 604, doi. 10.46883/2022.25920976
- By:
- Publication type:
- Article
MAF Amplification and Adjuvant Clodronate Outcomes in Early-Stage Breast Cancer in NSABP B-34 and Potential Impact on Clinical Practice.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 4, p. 1, doi. 10.1093/jncics/pkab054
- By:
- Publication type:
- Article
Validation of the NSABP/NRG Oncology 8-Gene Trastuzumab-benefit Signature in Alliance/NCCTG N9831.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 5, p. 1, doi. 10.1093/jncics/pkaa058
- By:
- Publication type:
- Article
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0114-x
- By:
- Publication type:
- Article
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted mutation detection in breast cancer using MammaSeq™.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-κB activation.
- Published in:
- EMBO Journal, 2008, v. 27, n. 2, p. 373, doi. 10.1038/sj.emboj.7601962
- By:
- Publication type:
- Article
A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer Metastasis.
- Published in:
- Endocrinology, 2021, v. 162, n. 8, p. 1, doi. 10.1210/endocr/bqab094
- By:
- Publication type:
- Article
Molecular drivers of lobular carcinoma in situ.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0580-5
- By:
- Publication type:
- Article
Molecular drivers of lobular carcinoma in situ.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 11, p. 2307
- By:
- Publication type:
- Article
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Finally, MALT1 is a protease!
- Published in:
- Nature Immunology, 2008, v. 9, n. 3, p. 231, doi. 10.1038/ni0308-231
- By:
- Publication type:
- Article
Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
- Published in:
- Nature Communications, 2015, v. 6, n. 1, p. 5908, doi. 10.1038/ncomms6908
- By:
- Publication type:
- Article
Use of enterally delivered angiotensin II type Ia receptor antagonists to reduce the severity of colitis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mixed invasive ductal lobular carcinoma is clinically and pathologically more similar to invasive lobular than ductal carcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 6, p. 1030, doi. 10.1038/s41416-022-02131-8
- By:
- Publication type:
- Article
Non-Hematopoietic β-Arrestin1 Confers Protection Against Experimental Colitis.
- Published in:
- Journal of Cellular Physiology, 2016, v. 231, n. 5, p. 992, doi. 10.1002/jcp.25216
- By:
- Publication type:
- Article
Canonical and Non-Canonical Roles of GRK2 in Lymphocytes.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 307, doi. 10.3390/cells10020307
- By:
- Publication type:
- Article
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0200836
- By:
- Publication type:
- Article
Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-Stage HER2-Positive Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
- Published in:
- Breast Cancer Research, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13058-024-01823-8
- By:
- Publication type:
- Article